Valuation: Danaher Corporation

Capitalization 150B 127B 115B 110B 205B 13,611B 213B 1,343B 533B 6,573B 564B 552B 22,972B P/E ratio 2025
45.3x
P/E ratio 2026 * 33.2x
Enterprise value 164B 138B 126B 120B 223B 14,825B 232B 1,463B 581B 7,159B 614B 601B 25,022B EV / Sales 2025
7.14x
EV / Sales 2026 * 6.29x
Free-Float
72.69%
Yield 2025 *
0.59%
Yield 2026 * 0.62%
1 day-1.10%
1 week-1.86%
Current month-2.88%
1 month-9.76%
3 months-3.90%
6 months+1.64%
Current year-7.14%
1 week 208.55
Extreme 208.55
220.86
1 month 208.55
Extreme 208.55
242.8
Current year 208.55
Extreme 208.55
242.8
1 year 171
Extreme 171
242.8
3 years 171
Extreme 171
281.7
5 years 171
Extreme 171
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO 54 31/12/2018
Chief Tech/Sci/R&D Officer - 24/08/2025
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1982
Director/Board Member 69 31/12/1982
Change 5d. change 1-year change 3-years change Capi.($)
-1.10%-1.86%+4.42%-18.20% 150B
-0.98%-7.00%-5.22%-12.21% 190B
+1.51%-0.47%-17.85%+98.20% 173B
+0.82%-2.02%-29.59%+56.70% 111B
+0.79%-1.74%-29.86%-20.76% 53.87B
-0.75%-3.61%-0.17%-2.24% 44.03B
+2.15%-0.38%-14.06%+15.71% 36.61B
+2.78%-7.02%+5.46%+17.35% 36.79B
+0.74%-2.91%-7.80%-18.62% 35.58B
-1.19%-1.96%-25.99%-42.05% 32.52B
Average +0.48%-2.49%-12.07%+7.39% 86.27B
Weighted average by Cap. +0.21%-2.46%-11.29%+18.71%

Financials

2025 2026 *
Net sales 24.53B 20.67B 18.85B 18B 33.41B 2,222B 34.71B 219B 87.05B 1,073B 91.99B 90.1B 3,750B 25.62B 21.59B 19.69B 18.8B 34.9B 2,321B 36.26B 229B 90.93B 1,121B 96.1B 94.12B 3,917B
Net income 3.7B 3.12B 2.85B 2.72B 5.04B 335B 5.24B 33.11B 13.14B 162B 13.89B 13.6B 566B 4.6B 3.87B 3.53B 3.37B 6.26B 416B 6.5B 41.08B 16.31B 201B 17.23B 16.88B 702B
Net Debt 13.41B 11.3B 10.31B 9.84B 18.27B 1,215B 18.98B 120B 47.59B 587B 50.29B 49.26B 2,050B 11B 9.27B 8.45B 8.07B 14.98B 996B 15.57B 98.33B 39.03B 481B 41.25B 40.4B 1,681B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (41% of net sales); - life sciences equipment (30.7%); - biotechnology equipment (28.3%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (41.6%), China (11.7%) and other (46.7%).
Employees
60,000
Date Price Change Volume
13/02/26 212.58 $ -1.10% 5,286,473
12/02/26 214.94 $ -2.29% 5,167,080
11/02/26 219.98 $ +0.10% 4,539,142
10/02/26 219.75 $ +1.43% 4,420,742
09/02/26 216.66 $ +0.02% 3,559,799
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
212.58USD
Average target price
264.86USD
Spread / Average Target
+24.59%

Quarterly revenue - Rate of surprise